MEDIPAL HOLDINGS CORPORATION announced an investment in mutex, which provides AI-powered medical claims support services for healthcare institutions. The investment was made through the MEDIPAL Innovation Investment Limited Partnership to facilitate the rollout of Reze and promote healthcare DX.
MEDIPAL HOLDINGS CORPORATION announced that it had invested in mutex, which provides a cloud-based service offering AI-powered medical claims support for healthcare institutions. The investment was made through the corporate venture capital (CVC) fund MEDIPAL Innovation Investment Limited Partnership, with the company stating that it would promote mutex's system development and the rollout of Reze.
Reze, provided by mutex, launched in July 2025. The service supports operational efficiency at healthcare institutions through AI-powered claim reviews, document generation, and the management of returned and assessed claims.
The investment is intended to promote the development of Reze's functions and its rollout, while MEDIPAL HOLDINGS CORPORATION is also considering opportunities for collaboration using its network of hospital customers.
mutex is based in Shinjuku, Tokyo. Through the investment, it is expected to contribute to mutex's business growth and the promotion of healthcare DX in Japan.